Centessa Pharmaceuticals plc
CNTA
$16.44
-$0.56-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -230.37M | -223.85M | -235.76M | -161.27M | -157.35M |
| Total Depreciation and Amortization | 615.00K | 625.00K | 648.00K | 660.00K | 664.00K |
| Total Amortization of Deferred Charges | 899.00K | 606.00K | 294.00K | 298.00K | 296.00K |
| Total Other Non-Cash Items | 67.75M | 67.70M | 70.60M | 36.45M | 32.92M |
| Change in Net Operating Assets | 17.22M | -7.10M | 22.16M | -6.45M | -22.84M |
| Cash from Operations | -143.89M | -162.02M | -142.06M | -130.31M | -146.31M |
| Capital Expenditure | -160.00K | -34.00K | -34.00K | -62.00K | -71.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -192.22M | -207.85M | 31.30M | -11.95M | -8.20M |
| Cash from Investing | -192.38M | -207.88M | 31.27M | -12.01M | -8.27M |
| Total Debt Issued | 109.34M | 109.34M | 109.34M | -- | -- |
| Total Debt Repaid | -110.10M | -110.10M | -110.10M | -- | -- |
| Issuance of Common Stock | 261.84M | 368.21M | 370.83M | 371.88M | 139.67M |
| Repurchase of Common Stock | -4.49M | -2.76M | -2.76M | -2.76M | -2.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.95M | -7.34M | -2.56M | -970.00K | -- |
| Cash from Financing | 253.64M | 357.35M | 364.75M | 368.15M | 136.91M |
| Foreign Exchange rate Adjustments | -502.00K | -509.00K | 1.23M | -2.31M | -185.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -83.13M | -13.06M | 255.19M | 223.53M | -17.85M |